Tiny blood samples, big clues: can we predict clots in newborn heart surgery?
NCT ID NCT06434207
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will collect leftover blood samples from 10 newborns with severe heart defects who have surgery at Boston Children's Hospital. Researchers want to understand why these babies are more likely to develop dangerous blood clots after surgery. They will look at tiny molecules called microRNAs in the blood to find patterns linked to clotting and inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward ways to predict or prevent dangerous blood clots in newborns with heart disease.
- What could go wrong
- This is a very small, early observational study with only 10 participants. It is not testing a treatment, so it may not lead to direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can a new device suck out deadly lung clots?
- Can community hospitals in zambia master severe disease care?
- App-Based exercise program aims to strengthen hearts in congenital disease